XM does not provide services to residents of the United States of America.
A
A

AdvMicroDev

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Nvidia notches record closing high as chip stocks advance

BUZZ-Nvidia notches record closing high as chip stocks advance Updates to market close, adds context ** Shares of AI darling Nvidia NVDA.O finish Mon up 2.4% at $138.07, a record high close as chip stocks outperform ** With rise on the session, NVDA just ~2% shy of its intraday all-time peak of $140.76 set on Jun 20 ** NVDA on the brink of dethroning Apple AAPL.O as the world's most valuable co as investors bet on strong demand for its next-generation Blackwell AI processors ** At Mon close, AAP
A
G
I
M
M
N
Q
A
K
L
T
U

Nvidia rises, eyes record as chip stocks advance

BUZZ-Nvidia rises, eyes record as chip stocks advance ** Shares of AI darling Nvidia NVDA.O rise as much as 3.6% to $139.60 on Mon and on track for record high close as chip stocks outperform ** NVDA last up 3% at $138.89 and within spitting distance of stock's intraday all-time peak of $140.76 achieved in Jun ** Stock adding to last week's 7.9% rally and now up ~180% YTD ** Goldman Sachs, which rates NVDA 'buy", boosted its PT late Fri by $15 to $150, inline with Wall Street median, per LSEG da
G
I
M
N
Q
A
K
L
T
U

TSMC third-quarter profit seen jumping 40% on strong AI chip demand

PREVIEW-TSMC third-quarter profit seen jumping 40% on strong AI chip demand Analysts expect third-quarter profit of $9.27 bln Q3 revenue jumps, beats market expectations Stock price has leapt on chip demand for AI applications Earnings call at 0600 GMT on Thursday By Ben Blanchard and Faith Hung TAIPEI, Oct 14 (Reuters) - Taiwan Semiconductor Manufacturing Co 2330.TW , the main producer of advanced chips used in artificial intelligence applications, is expected to report a 40% leap in third-quar
A
I
N
Q
A
T

U.S. ANI Pharmaceuticals, Deere & Co, Zoetis

U.S. RESEARCH ROUNDUP-ANI Pharmaceuticals, Deere & Co, Zoetis Oct 11 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including ANI Pharmaceuticals, Deere & Co and Zoetis, on Friday. HIGHLIGHTS * ANI Pharmaceuticals Inc ANIP.O : Piper Sandler initiates coverage with overweight rating * Deere & Co DE.N : JP Morgan raises target price to $420 from $360 * Northrop Grumman NOC.N : Citigroup raises target price to $587 from $521 * S
A
C
G
H
I
A
C
F
A
C
A
A
C
C
C
E

Nasdaq top and bottom performing stocks at about 03:45 p.m. EDT

BUZZ - Nasdaq top and bottom performing stocks at about 03:45 p.m. EDT Nasdaq 100 .NDX Top Performers Percent Change MongoDB Inc MDB.OQ +6.6% CrowdStrike Holdings Inc CRWD.OQ +5.3% Zscaler Inc ZS.OQ +5.2% Micron Technology Inc MU.OQ +4.0% Atlassian Corp TEAM.OQ +3.6% Bottom Performers Percent Change Advanced Micro Devices Inc AMD.OQ -4.7% Moderna Inc MRNA.OQ -3.6% Verisk Analytics Inc VRSK.OQ -3.5% Cognizant Technology Solutions Corp CTSH.OQ -3.0% Warner Bros Discovery Inc WBD.OQ -2.9% The Nasda
C
M
V
A
U
A
C

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.